Background illustration for clinical trials search

Paid Clinical Trials Ogden

Discover 1,089 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Salt Lake City UT, Boise ID, Denver CO, Aurora CO,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

Pediatric Cervical Spine Clearance: A Multicenter Prospective Observational Study

for
Cervical Spine Fracture
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 0 - 17

Code: NCT05608460

Recruiting

A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)

for
Congenital Diaphragmatic Hernia, Pulmonary Hypertension
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 0+

Code: NCT05201144

Phase 2, Recruiting

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

for
Heterozygous or Homozygous Familial Hypercholesterolemia
Location: Salt Lake City UT
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 70+

Code: NCT05682378

Phase 3, Recruiting

Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment

for
Homocystinuria
Location: Salt Lake City UT, Phoenix AZ, Dallas TX, Chicago IL,
Sponsor: Travere Therapeutics, Inc.

Sex: All

Age: 12 - 65

Code: NCT06247085

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

for
Congenital Diaphragmatic Hernia
Location: Salt Lake City UT, Aurora CO, Los Angeles CA,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0

Code: NCT05213676

Recruiting

A Novel mHealth Intervention to Improve Outcomes of Children With Medical Complexity

for
Children With Medical Complexity
Location: Salt Lake City UT, Chicago IL
Sponsor: University of Utah

Sex: All

Age: 1 - 18

Code: NCT06883045

Recruiting

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Salt Lake City UT, Aurora CO, Oakland CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 2 - 18

Code: NCT05711667

Phase 3, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Salt Lake City UT, Aurora CO, Phoenix AZ,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase 1, Phase 2, Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Salt Lake City UT, Lehi UT, Aurora CO, Madera CA,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Salt Lake City UT, Denver CO, Aurora CO, Reno NV,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Salt Lake City UT, Boise ID, Denver CO, Aurora CO,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

for
Metastatic Ewing Sarcoma
Location: Salt Lake City UT, Phoenix AZ, Nashville TN,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 1+

Code: NCT07194044

Phase 1, Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Salt Lake City UT, Aurora CO, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07630974

Phase 1, Phase 2, Recruiting

Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)

for
Community Acquired Pneumonia (CAP),
Location: Salt Lake City UT, Chicago IL, Atlanta GA,
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

Sex: All

Age: 1 - 5

Code: NCT06986148

Recruiting

Optimizing Pain Treatment in Children On Mechanical Ventilation

for
Mechanical Ventilation, Pediatric Acute Respiratory Failure,
Location: Salt Lake City UT, Minneapolis MN, Little Rock AR,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 0 - 17

Code: NCT06994442

Phase 3, Recruiting

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Salt Lake City UT, Aurora CO, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT06941272

Phase 1, Phase 2, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Salt Lake City UT, Boise ID, Denver CO, Aurora CO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Salt Lake City UT, Boise ID, Aurora CO, Las Vegas NV,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Salt Lake City UT, Denver CO, Aurora CO, Las Vegas NV,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting